Stephen Lin

Stephen Lin currently serves as the Chief Safety Officer at Johnson & Johnson Innovative Medicine and the Corporate Secretary at TransCelerate BioPharma Inc. Previously, Stephen held various leadership roles at Sanofi from May 2008 to September 2022, including Chief Safety Officer and Senior Vice President, Global Head of Pharmacovigilance. Additional positions at Sanofi involved oversight of medical safety, strategic operations in North America Medical Affairs, and leadership in safety surveillance and risk management across multiple therapeutic areas. Stephen's extensive career also includes significant contributions to pharmacovigilance at organizations such as Millennium Pharmaceuticals and sanofi-aventis Pharmaceuticals. Education includes a medical degree from The George Washington University School of Medicine and Health Sciences, alongside a biology bachelor's degree from The Johns Hopkins University.